Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DM5PA2
|
|||
| Drug Name |
ASP0598
|
|||
| Drug Type |
Recombinant protein
|
|||
| Indication | Chronic tympanic membrane perforation [ICD-11: AB13] | Phase 1 | [1] | |
| Company |
Astelllas
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT04305184) A Phase 1/2, Randomized, Placebo-controlled Study to Assess the Safety, Tolerability, Efficacy, and Pharmacokinetics of ASP0598 Otic Solution Following Topical Application Into the Ear in Subjects With Chronic Tympanic Membrane Perforation (CTMP). U.S.National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.